Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond C Love

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Journal of Psychiatric Research|May 19, 2012
Alcohol and cannabis use and mortality in people with schizophrenia and related psychotic disordersMaju Mathew Koola, Robert P McMahon, Heidi J Wehring, et al.
Schizophrenia Research|August 31, 2010
The relationship of brain weight to body mass index (BMI) upon autopsy in young people with severe mental illnessHeidi J Wehring, Fang Liu, Robert P McMahon, et al.
Schizophrenia Bulletin|December 19, 2009
Cigarette smoking and mortality risk in people with schizophreniaDeanna L Kelly, Robert P McMahon, Heidi J Wehring, et al.
Clinical Neuropharmacology|August 3, 2005
Risperidone, quetiapine, and fluphenazine in the treatment of patients with therapy-refractory schizophreniaRobert R Conley, Deanna L Kelly, Matthew W Nelson, et al.
Schizophrenia Research|March 31, 2022
Anti-aggressive effects of clozapine in involuntarily committed black patients with severe mental illnessVincent S Cavaliere, Matthew Glassman, Bethany A DiPaula, et al.
Nutrients|January 10, 2026
Mitigating Weight Gain Side Effects by Reducing Sugar-Sweetened Beverage Consumption in Youth Newly Prescribed Second-Generation Antipsychotic MedicationKristin Bussell, Heidi Wehring, Susan dosReis, et al.
Clinical Schizophrenia & Related Psychoses|July 29, 2015
Blood Draw Barriers for Treatment with Clozapine and Development of a Point-of-Care Monitoring DeviceDeanna L Kelly, Hadar Ben-Yoav, Gregory F Payne, et al.
The Journal of Nervous and Mental Disease|November 3, 2015
The Family Value of Information, Community Support, and Experience Study: Rationale, Design, and Methods of a "Family-Centered" Research StudyGloria M Reeves, Heidi J Wehring, Kathleen M Connors, et al.
Schizophrenia Bulletin|June 15, 2025
A Randomized Controlled Trial of an Extension for Community Healthcare Outcomes (ECHO) Tele-mentoring Program to Increase Clozapine UtilizationDeanna L Kelly, Jared Hunt, Gopal Vyas, et al.
Schizophrenia Research|August 26, 2023
Clozapine and neutrophil response in patients of African descent: A six-month, multinational, prospective, open-label clinical trialDeanna L Kelly, Matthew Glassman, Ikwunga Wonodi, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Journal of Psychiatric Research|May 19, 2012
Alcohol and cannabis use and mortality in people with schizophrenia and related psychotic disordersMaju Mathew Koola, Robert P McMahon, Heidi J Wehring, et al.
Schizophrenia Research|August 31, 2010
The relationship of brain weight to body mass index (BMI) upon autopsy in young people with severe mental illnessHeidi J Wehring, Fang Liu, Robert P McMahon, et al.
Schizophrenia Bulletin|December 19, 2009
Cigarette smoking and mortality risk in people with schizophreniaDeanna L Kelly, Robert P McMahon, Heidi J Wehring, et al.
Clinical Neuropharmacology|August 3, 2005
Risperidone, quetiapine, and fluphenazine in the treatment of patients with therapy-refractory schizophreniaRobert R Conley, Deanna L Kelly, Matthew W Nelson, et al.
Schizophrenia Research|March 31, 2022
Anti-aggressive effects of clozapine in involuntarily committed black patients with severe mental illnessVincent S Cavaliere, Matthew Glassman, Bethany A DiPaula, et al.
Nutrients|January 10, 2026
Mitigating Weight Gain Side Effects by Reducing Sugar-Sweetened Beverage Consumption in Youth Newly Prescribed Second-Generation Antipsychotic MedicationKristin Bussell, Heidi Wehring, Susan dosReis, et al.
Clinical Schizophrenia & Related Psychoses|July 29, 2015
Blood Draw Barriers for Treatment with Clozapine and Development of a Point-of-Care Monitoring DeviceDeanna L Kelly, Hadar Ben-Yoav, Gregory F Payne, et al.
The Journal of Nervous and Mental Disease|November 3, 2015
The Family Value of Information, Community Support, and Experience Study: Rationale, Design, and Methods of a "Family-Centered" Research StudyGloria M Reeves, Heidi J Wehring, Kathleen M Connors, et al.
Schizophrenia Bulletin|June 15, 2025
A Randomized Controlled Trial of an Extension for Community Healthcare Outcomes (ECHO) Tele-mentoring Program to Increase Clozapine UtilizationDeanna L Kelly, Jared Hunt, Gopal Vyas, et al.
Schizophrenia Research|August 26, 2023
Clozapine and neutrophil response in patients of African descent: A six-month, multinational, prospective, open-label clinical trialDeanna L Kelly, Matthew Glassman, Ikwunga Wonodi, et al.
Pageof 5